LifeStance Health Group has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting a positive shift in its earnings outlook. The upgrade is driven by a 42.3% increase in the Zacks Consensus Estimate for the company over the past three months. For the fiscal year ending December 2026, the outpatient mental health services provider is expected to earn $0.12 per share, unchanged from the prior year. The Zacks Rank system places LifeStance Health in the top 5% of more than 4,000 covered stocks, indicating superior earnings estimate revision activity that could lead to near-term stock price gains.
Lifestance Health Group IncUpgraded to Zacks Rank #1 Strong Buy due to 42.3% increase in consensus earnings estimate, indicating positive earnings revision momentum.